Short answer
Definium Therapeutics, Inc. (DFTX) filed an 8-K current report with the SEC on May 19, 2026 reporting Item 8.01 (Other Events). Updated corporate presentation posted May 19, 2026.
Definium Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Updated corporate presentation posted May 19, 2026
- Presentation likely contains current business, pipeline, or strategic updates relevant to investors
- Exhibit 99.1 provides the substantive disclosure for shareholder review
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Definium Therapeutics, Inc. 8-K filings
Get the next DFTX 8-K as it lands
Follow DFTX for push alerts, or ask the research agent what this filing means.